2021 ACR Guidance for Adjusting Immunomodulatory Therapy related to the COVID-19 Vaccine in Patients with Rheumatic & MSK Diseases No Dose Adjustment Needed: - Apremilast, Azathioprine, Belimumab, Calcineurin Inhibitors (oral), Cyclophosphamide (oral), Glucocorticoids, Hydroxychloroquine, IL-1R, IL-6R, IL-17, IL-12/23, IL-23, IVIG, Leflunomide, Sulfasalazine, TNF inhibitors Consider Immunomodulatory Rx Adjustment: - Acetaminophen / NSAIDs, Abatacept, Cyclophosphamide, JAK inhibitors, Methotrexate, Mycophenolate, Rituximab https://doi.org/10.1002/art.41877 Mithu Maheswaranathan, MD @MithuRheum #ACR2021 #Guidelines #COVID19 #management #rheumatology #vaccine
